TOI
Oncology Institute IncNASDAQHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$400.30M
P/E Ratio
—
EPS
$-0.54
Beta
0.20
52W High
$4.88
52W Low
$2.02
50-Day MA
$3.15
200-Day MA
$3.44
Dividend Yield
—
Profit Margin
-12.10%
Forward P/E
—
PEG Ratio
—
About Oncology Institute Inc
Oncology Institute Inc (ticker: TOI) is a pioneering healthcare organization dedicated to transforming cancer care through its extensive network of specialized clinics and innovative treatment modalities. The company prioritizes enhanced patient outcomes by leveraging state-of-the-art technologies and customized treatment plans, while also participating in clinical trials and collaborations with leading research institutions. As the need for advanced cancer therapies continues to grow, TOI is strategically positioned to leverage its robust pipeline and deep-seated oncology expertise, reinforcing its status as a key player in the evolving healthcare sector.
Fundamentals
| Revenue (TTM) | $502.73M |
| Gross Profit (TTM) | $76.44M |
| EBITDA | $-29.14M |
| Operating Margin | -4.87% |
| Return on Equity | -652.00% |
| Return on Assets | -13.40% |
| Revenue/Share (TTM) | $5.44 |
| Book Value | $-0.16 |
| Price-to-Book | 0.76 |
| Price-to-Sales (TTM) | 0.80 |
| EV/Revenue | 0.936 |
| EV/EBITDA | 8.53 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.60% |
| Shares Outstanding | $98.84M |
| Float | $64.93M |
| % Insiders | 19.91% |
| % Institutions | 44.55% |
Historical Volatility
HV 10-Day
59.04%
HV 20-Day
51.53%
HV 30-Day
58.58%
HV 60-Day
77.41%
HV Rank
8.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($7.00 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/2/2026